Ht. Lee et Pwk. Woo, Atorvastatin, an HMG-CoA reductase inhibitor and effective lipid-regulating agent. Part II. Synthesis of side-chain-labeled [C-14]atorvastatin., J LABEL C R, 42(2), 1999, pp. 129-133
[C-14]Atorvastatin was synthesized in a ten-step sequence with an overall y
ield of 5.7%. The label was introduced as sodium [1-C-14]acetate, which was
converted via the acid chloride to the (S)-2-hydroxy-1,2,2-triphenylethyl
ester 4. Chiral condensation of 4 with aldehyde 5 gave the chiral ester int
ermediate 6 with a yield of about 70%. Following transesterification of 6 t
o a methyl ester and condensation with tert-butyl lithioacetate to give (R)
-beta-ketoester S, a second chiral center was generated by reduction of the
hydroxyketone 8, giving the (R,R)-dihydroxy ester 9, which was then conver
ted via the acid to the lactone 11. The desired pure diastereomer 11, obtai
ned from the mother liquor during crystallization, was then converted to th
e corresponding calcium salt (2:1) 13 (atorvastatin).